礼来Eli Lilly & Co. (LLY) 2012年年度报告「NYSE」.pdf

1、Progress AgAinst Alzheimers DiseAseEli lilly and Company2012 annual REpoRtnotiCE of 2013 annual mEEtingpRoxy StatEmEntYear in Review 1 Financial Highlights 2 Letter to Shareholders 6 Progress Against Alzheimers Disease 10 Pipeline of Molecules in Clinical DevelopmentForm 10-K 3 Business 16 Risk Fact

2、ors 19 Properties 20 Legal Proceedings 23 Managements Discussion and Analysis of Results of Operations and Financial Condition 40 Consolidated Statements of Operations 41 Consolidated Statements of Comprehensive Income 42 Consolidated Balance Sheets 43 Consolidated Statements of Cash Flows 44 Segmen

3、t Information 46 Selected Quarterly Data 47 Selected Financial Data 49 Notes to Consolidated Financial Statements 82 Managements Reports 84 Reports of Independent Registered Public Accounting FirmFor more information on Lillys commitment to corporate responsibility,please see the inside back cover o

4、f this report.the lilly PromiseOur MissionLilly makes medicines that help people live longer,healthier,more active lives.Our ValuesIntegrity|Excellence|Respect for PeopleWe promise to operate our business with absolute integrity and earn the trust of all,set the highest standards for our performance

5、 and for the performance of our products,and demonstrate caring and respect for all those who share in our mission and are touched by our work.Our VisionWe will make a significant contribution to humanity by improving global health in the 21st century.Starting with the work of our scientists,we will

6、 place improved outcomes for individual patients at the center of what we do.We will listen carefully to understand patient needs and work with health care partners to provide meaningful benefits for the people who depend on us.Our StrategyWe will create value for all our stakeholders by accel-erati